Stock listing

SIX Swiss:MMTX MindMaze Therapeutics Holding SA Aktie

Home listing (SIX Swiss) of MindMaze Therapeutics Holding SA

Follow MindMaze Therapeutics Holding SA into a list and get an email when it puts out news.

Share price · SIX:MMTX

0.145 CHF -0.004 (-2.4%)

Close on Oct 15, 2026

MindMaze Therapeutics Holding SA logo
Ticker
SIX Swiss:MMTX
Asset type
Stock
Exchange
SIX Swiss
Currency
CHF

What changed lately

Latest news

MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation

Sep 17, 2026

MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences

Sep 1, 2026

MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update

Aug 27, 2026

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

Aug 12, 2026

MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing

Aug 10, 2026

MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy

Jul 9, 2026

MindMaze Therapeutics Announces Results of Annual General Meeting

Jun 25, 2026

MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting

Jun 3, 2026

MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification

Jun 2, 2026

MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing

May 26, 2026

All MindMaze Therapeutics Holding SA news

Financings

  • Strategic investment of treasury shares and mandatory convertible loan notes converted into ordinary shares

    Aug 10, 2026 · US$4.94M

    Tranche closed: CHF 4M raised

    Buyers: Neuro.io Group SA (CHF 8.0 million strategic equity financing; first tranche of CHF 4.0 million completed, second CHF 4.0 million tranche expected in September and November 2026)

    Use of proceeds: Support U.S. commercial priorities and advancement of the neurotherapeutics platform

    Tranche closed Aug 10, 2026

Read by 6ix AI from the company's releases

Decks

MindMaze Therapeutics Holding SA on 6ix

News releases
18 in the last 12 months · 18 in all · newest Sep 17, 2026 · oldest 2025
Decks
3 decks · latest September 2026

Where MindMaze Therapeutics Holding SA is listed

ListingExchangeCountryCurrency
SIX Swiss:MMTX · Home listing · This pageSIX SwissSwitzerlandCHF
OTC:RLFTFOTCUnited StatesUSD
OTC:RLFTYOTCUnited StatesUSD
LSE:0QKQLSEUnited KingdomCHF
Lang & Schwarz:A3EFB5Lang & SchwarzGermanyEUR
LS Exchange:A3EFB5LS ExchangeGermanyEUR
Aquis:MMTXZAquisUnited KingdomCHF
gettex:V6MgettexGermanyEUR
BX Swiss:MMTXBX SwissSwitzerlandCHF
Munich:V6MMunichGermanyEUR
Turquoise:MMTXZTurquoiseUnited KingdomCHF
Frankfurt:V6MFrankfurtGermanyEUR
Munich:V6M1MunichGermanyEUR
Stuttgart:V6MStuttgartGermanyEUR
OTC:MMTZFOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about MindMaze Therapeutics Holding SA.